Senior Research Fellow, ANZIC-RC, Monash University Professor, Researcher and Intensivist, HIAE A/Prof, University of São Paulo
Melbourne
Joined February 2020
- Tweets272
- Following372
- Followers774
- Likes2.6K
Ary Serpa Neto retweeted
📣 In this week's PCT Grand Rounds, @a_serpaneto of Monash University and @Austin_Health will present “Sodium Bicarbonate for Metabolic Acidosis in the Intensive Care Unit.” Join us! #pctgr
🔗 duke.is/pctnews20260715
Ary Serpa Neto retweeted
Bicarbonate in Critically Ill Patients - SODa-BIC
Prof. Ary Serpa Neto
Prof. Boris Jung
@a_serpaneto
youtu.be/PxSG7XUgakQ?is=pz35… via @YouTube
Ary Serpa Neto retweeted
📊 #StatShotSaturdays #IJCCM
⚡ p-value tells if result is statistically significant.
🧠 Bayesian statistics tells if a treatment is likely to work.
📖 Read:
ijccm.org/doi/IJCCM/pdf/10.5…
@Drnasap @shultzie @TripathySwagata @tonny_veenith @a_serpaneto
Ary Serpa Neto retweeted
The 2nd trial for CCR Frankfurt is CONFIDENCE
To be presented by Frederique Paulus & Siebe Blok
Can lung ultrasound-guided fluid removal increase ventilator-free days?
Join us 22–23 February, 2027
Registration opens shortly
criticalcarereviews.com/meet… #CCRFrankfurt
🤖 Made with AI
ALT Flyer for the CONFIDENCE trial results at CCR Frankfurt
Ary Serpa Neto retweeted
Original Article: Sodium Bicarbonate for Critically Ill Adults with Metabolic Acidosis and Shock (SODa-BIC trial) nej.md/4ofXcyq
Editorial: Sodium Bicarbonate in Critical Illness — A New Chapter for the Book nej.md/4xXBXpm
#Nephrology #EmergencyMedicine
ALT This image contains three panels of a clinical study graph and tables. Panel A displays a Kaplan-Meier survival curve comparing in-hospital survival by day 30 between sodium bicarbonate and placebo. Panel B shows a similar curve for renal-replacement therapy by day 30. Panel C contains a forest plot analyzing major adverse kidney events within 30 days across various subgroups, highlighting differences between sodium bicarbonate and placebo.
Ary Serpa Neto retweeted
If you have troubles accessing editorials describing clinical practice implications of the #LOGICALtrial and #SodaBICtrial then go to the Crit Care Resusc website and look at articles in press #CCR26
Ary Serpa Neto retweeted
Sodium bicarbonate in critical illness: Correcting acidaemia without changing outcomes?
CCR Journal Watch
criticalcarereviews.com/late…
Ary Serpa Neto retweeted
The impact factor for @CCRJournal increased by 88% last year (the largest increase of any critical care journal). We are now a Q2 journal. Our journal is free online & we are doing our best to publish interesting content. Here is the June issue sciencedirect.com/journal/cr…
Ary Serpa Neto retweeted
Episode 95 - bicarb, bicarb, bicarb. We talk about 2 new studies of bicarbonate presented at #CCR2026 @CritCareReviews. How should we think about these trials and the use of bicarbonate in our clinical practice?
icuedandtoddcast.buzzsprout.…
Ary Serpa Neto retweeted
➡️ Does bicarbonate improve outcomes in in-hospital cardiac arrest?
➡️ Or could correcting acidosis during CPR be ineffective—or even harmful?
➡️ Join us in June to hear the BIHCA trial results
Register now: criticalcarereviews.com/meet…
ALT Flyer for the BIHCA trial result
Ary Serpa Neto retweeted
Join our March Webinar - @a_serpaneto explores the rationale behind the Daily Ordinal Scale for ECMO patients including its development with consumers.
8.00am Melbourne/AEDT
25 March 2025
REGISTER NOW 👉 internationalecmonet.org/res…
@CCRG_Research
@MonashUni
Ary Serpa Neto retweeted
🎄 On the 9th day of Christmas, my true love gave to me
🎁 8.4% bicarbonate
🧪 ≥7.30 pH target
💉 5-hour infusion
📊 4 metabolic acidosis criteria
🎅 3 countries recruiting
🎶 Two randomised groups
🍐 And an acidotic partridge in a pear tree
#CCR26
criticalcarereviews.com/meet…
Ary Serpa Neto retweeted
Nice work from @AbhiDuggalMD @l_bulgarelli @rod_deliberato @a_serpaneto et al.
ARDS subphenotypes predict risk & show that neuromuscular blockers shouldn’t be used routinely—signal of benefit only in hypoinflammatory (A); none in hyperinflammatory (B).
chestcc.org/article/S2949-78…
Ary Serpa Neto retweeted
📣 Call for Papers ! Systematic Reviews & Meta-Analysis
Critical Care Science welcomes submissions of #SystematicReviews & MetaAnalyses 🗝️topics in #ICU #PedsICU
💎 Open Access:
No APCs. No submission fees
👉 Submit your manuscript at:
criticalcarescience.org
#Foamed
Ary Serpa Neto retweeted
A special issue from @CCRJournal honouring the legacy of Rinaldo Bellomo
Grab a coffee, sit back, read and smile.
Such an incredible person.
An uplifting tribute.
Kudos to the authors for sharing their experiences
sciencedirect.com/journal/cr…
ALT Screenshot of this issue from Critical Care & Resuscitation Journal
Ary Serpa Neto retweeted
Can inhaled nebulized heparin save lives? the answer is yes and the mechanism of action is beautifully explained in the image
published few minutes ago by @a_serpaneto
kwnsfk27.r.eu-west-1.awstrac…
Ary Serpa Neto retweeted
Development of a New Longitudinal Ordinal Outcome for Clinical Trials in ECMO Patients
An outcome measuring daily organ support for patients on ECMO performed well compared with a patient-centered outcome
@a_serpaneto @iculisah @anzicrc @Monash_SPHPM
tinyurl.com/ysd8m2w2
Ary Serpa Neto retweeted
Editor in Chief @NEJM speaking at #PratoICM25 about “why we should believe what we read” and how we deal with research misconduct
Ary Serpa Neto retweeted
In memory of professor Rinaldo Bellomo: A giant of intensive care medicine
CCR Journal Watch - tracking the critical care literature daily
doi.org/10.1016/j.ccrj.2025.…
Ary Serpa Neto retweeted
In memory of professor Rinaldo Bellomo: A giant of intensive care medi... sciencedirect.com/science/ar…